top of page

QuickDerm® Wound Ointment by VetCare® leverages advances in medical science for use in treating wounds and other conditions in equines and other animals.

Medical science has seen dramatic advances in innovative wound-care protocols. Once a matter of simple wet saline dressings, wounds can now be better managed by a number of new techniques, including a family of compounds known as protease down-regulators. When these matrixmetalloproteinases (MMPs) are over-produced, the wound healing cascade becomes unbalanced.

In a typical open wound, new tissue is grown while old, necrotic tissue is removed and sloughed off by the body. This series of events is regulated by specific enzymes (proteases) which act to govern the rate at which new tissue is grown. Unfortunately, these proteases can become over-active and slow the healing in acute and chronic wounds.

This is the case in such common wounds as decubitus sores, traumatic injuries, diabetic foot ulcers and first degree wounds from burns. VetCare has transferred a wound-management product technology which has been used for human application in the past to the veterinary market to develop QuickDerm.

Applied topically once a day, QuickDerm Ointment adheres well to wounds. It forms a protective barrier for the wound, retains moisture and will not rub off. It impacts inflammation, promotes healing and helps inhibit proud flesh. Made in the USA without caustic or toxic ingredients, QuickDerm is affordable, will not test and has a shelf life of three years, during which heat and cold do not affect quality.

Indications for equine use:

Lacerations

Wire cuts

Cracked heels/Mud fever

Rain rot

Scratches

Speed cuts

Heel and Quarter Grabs

Quarter cracks

Burns

Secondary wounds/Post surgery

Sarcoids

Made in USA.

2 ounces.

QuickDerm Wound care ointment

$29.99Price
Quantity
  • Ingredients:
    Polyethylene glycols, water, citric acid, potassium citrate, sodium citrate, benzoic acid, salts of rubidium, calcium and zinc.

  • Product Information

    In the last few years, medical science has seen dramatic advances in new and innovative wound-care protocols. Once a matter of simple wet saline dressings, wounds can now be better managed by a number of new techniques, including a family of compounds known as protease down-regulators. When these matrixmetalloproteinases (mmp's) are over-produced, the wound healing cascade becomes unbalanced.

    In a typical open wound, new tissue is grown as old, necrotic tissue is removed and sloughed off by the body. This series of events is regulated by specific enzymes (proteases) which act to govern the rate at which new tissue is grown. Unfortunately, these proteases can become over-active and slow the healing in acute and chronic wounds.

    This is the case in such common wounds as decubitus sores, traumatic injuries, diabetic foot ulcers, and first degree wounds from burns. VetCare has transferred a wound-management product technology which has been used by others for human application in the past, to the veterinary market.

bottom of page